Title | Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Meliti A, Sadimin E, Diolombi M, Khani F, Epstein JI |
Journal | Prostate |
Volume | 77 |
Issue | 6 |
Pagination | 681-685 |
Date Published | 2017 May |
ISSN | 1097-0045 |
Keywords | Adenocarcinoma, Biopsy, Needle, Humans, Male, Neoplasm Grading, Prospective Studies, Prostatic Neoplasms |
Abstract | BACKGROUND: Recognition of Gleason pattern 4 in prostatic needle biopsies is crucial for both prognosis and therapy. Recently, it has been recommended to record percent pattern 4 when Gleason score 7 cancer is the highest grade in a case. METHODS: Four hundred and five prostate needle core biopsies received for a second opinion at our institution from February-June, 2015 were prospectively diagnosed with prostatic adenocarcinoma Gleason score 7 as the highest score on review by a consultant urological pathologist. Percentage of core involvement by cancer, percentage of Gleason pattern 4 per core, distribution of Gleason pattern 4 (clustered, scattered), morphology of pattern 4 (cribriform, non-cribriform), and whether the cancer was continuous or discontinuous were recorded. RESULTS: Better agreement was noted between the consultant and referring pathologists when pattern 4 was clustered as opposed to dispersed in biopsies (P = 0.009). The percentage of core involvement by cancer, morphology of pattern 4, and continuity of cancer did not affect the agreement between the consultant and referring pathologists. There was a trend (P = 0.06) for better agreement based on the percent of pattern 4. CONCLUSIONS: When pattern 4 is scattered amongst pattern 3 as opposed to being discrete foci, there is less interobserver reproducibility in grading Gleason score 7 cancer, and in this setting pathologists should consider obtaining second opinions either internally within their group or externally. Prostate 77: 681-685, 2017. © 2017 Wiley Periodicals, Inc. |
DOI | 10.1002/pros.23314 |
Alternate Journal | Prostate |
PubMed ID | 28155999 |
Related Faculty:
Francesca Khani, M.D.